Latest Close
₹8,200.00
+5.24%
Connecting…
Day Range
-
Full OHLC pending
Volume
-
Full session data pending
50 DMA
₹8,752.12
200 DMA
₹8,033.40
1 year gain / loss
+₹410.00(+5.26%)
₹7,790.00 → ₹8,200.00· 2025-10-30 to 2026-10-30
Charting by TradingView
This stock does not satisfy the default swing-support rules at the selected chart endpoint. Its price, volume and moving averages remain available for manual research.
Snapshot 2026-10-31 · Financial period Jun 2026 · Consolidated figures where available
Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,000 plus beds across 73 hospitals, 5000 plus pharmacies and 378 plus clinics and diagnostic centers, as well as 200 telemedicine centers.
Market Cap
₹1,20,779.11 Cr
P/E
55.61×
Sector 78.65× · below
P/B
12.74×
Sector 3.52× · above
EV / EBITDA
29.58×
Sector 19.82× · above
ROE
20.48%
Sector -30.53%
ROCE
17.27%
Sector 10.75%
ROA
9.79%
Sector 4.02%
Cash Flow / Profit
1.43×
| Period | Revenue | Operating profit | Net profit |
|---|---|---|---|
| Jun 2026 | 7,092.3 +6.7% | 798.8 | 610.4 +10.7% |
| Mar 2026 | 6,649.4 +1.8% | 721.5 | 551.3 +6.8% |
| Dec 2025 | 6,530.2 +2.7% | 682 | 516.3 +4.5% |
| Sep 2025 | 6,358.2 | 674.7 | 494 |
Dividend
14 Aug 2026 · ₹10
Dividend
16 Feb 2026 · ₹10